Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Pentoxifylline Versus Cilostazol
Condition:   Peripheral Artery Disease Interventions:   Drug: Pentoxifylline;   Drug: Cilostazol Sponsors:   Brigham and Women's Hospital;   National Institute on Aging (NIA);   Rutgers University;   Johns Hopkins University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2022 Category: Research Source Type: clinical trials